Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

ISS - Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera

Company: Spexis AG Date: 2024-04-17 Language: English Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: